Leaching of Lopinavir Amorphous Solid Dispersions in Acidic Media
- 460 Downloads
Amorphous solid dispersions (ASDs) formulated with acid-insoluble (enteric) polymers form suspensions in acidic media where the polymer is largely insoluble. However, a small amount of drug can dissolve and a supersaturated solution may be generated. The goal of this study was to gain insight into the leaching mechanisms of both drug and polymer from the suspended particles, studying the impact of solution additives such as surfactants.
ASDs were prepared by spray drying lopinavir (LPV) with an enteric polymer, either hydroxypropylmethylcellulose acetate succinate (HPMCAS) or hydroxypropylmethylcellulose phthalate (HPMCP). Four surfactants and a suspending agent were added to the liquid media to evaluate the effect of these excipients on leaching. pH 3 and pH 5 buffers were used to investigate the effect of pH.
The extent of drug leaching from the amorphous formulation was proportional to the crystalline solubility of the drug in the same medium. All surfactants promoted solubilization of LPV with the exception of poloxamer and sodium dodecyl sulfate-HPMCP combinations. A small amount of polymer ionization significantly enhanced LPV leaching in solutions containing an ionic surfactant.
The mechanism of enhanced leaching appeared to be solubilization, with the apparent supersaturation remaining the same for systems containing the same polymer.
KEY WORDSamorphous suspensions leaching solubilization surfactants
Amorphous solid dispersion
Critical aggregation concentration
Critical micelle concentration
High performance liquid chromatography
Hydroxypropylmethylcellulose (hypromellose) acetate succinate
Limit of detection
Limit of quantitation
Sodium dodecyl sulfate
- 8.Chen X-Q, Stefanski K, Shen H, Huang C, Caporuscio C, Yang W, et al. Oral delivery of highly lipophilic poorly water-soluble drugs: spray-dried dispersions to improve oral absorption and enable high-dose toxicology studies of a P2Y1 antagonist. J Pharm Sci. 2014;103(12):3924–31.CrossRefPubMedGoogle Scholar
- 12.Chen J, Ormes JD, Higgins JD, Taylor LS. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles. Mol Pharm. 2015;12(2):533–41.Google Scholar
- 13.Raina S, Zhang GZ, Alonzo D, Wu J, Zhu D, Catron N, et al. Impact of solubilizing additives on supersaturation and membrane transport of drugs. Pharm Res. 2015:1–15;32(10):3350–64.Google Scholar
- 16.Ashland. AquaSolveTM hydroxypropylmethylcellulose acetate succinate: physical and chemical properties handbook. Available from: http://www.ashland.com/Ashland/Static/Documents/ASI/PC_12624_AquaSolve_AS_Handbook.pdf.
- 18.Ilevbare G, Marsac P, Mitra A. Performance and characterization of amorphous solid dispersions: an overview. In: Templeton AC, Byrn SR, Haskell RJ, Prisinzano TE, editors. Discovering and developing molecules with optimal drug-like properties. New York: Springer; 2015. p. 287–343.Google Scholar
- 19.Mullin JW. Crystallization. London: Butterworths; 2001.Google Scholar
- 23.Trasi NS, Taylor LS. Thermodynamics of highly supersaturated aqueous solutions of poorly water-soluble drugs—impact of a second drug on the solution phase behavior and implications for combination products. J Pharm Sci. 2015:2583–2593.Google Scholar
- 24.Kwak JCT. Polymer-surfactrant systems: CRC Press; 1998.Google Scholar
- 31.Chen J, Mosquera-Giraldo LI, Ormes JD, Higgins JD, Taylor LS. Bile salts as crystallization inhibitors of supersaturated solutions of poorly water-soluble compounds. Cryst Growth Des. 2015;15(6):2593–7.Google Scholar